FDA warns Curaleaf about inflated claims in CBD product marketing
5 years ago
19
A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain.
Loading comments...
-
2:48
WFTX
1 year agoYour Healthy Family: Acknowledging and handling grief
617 -
0:42
KMGH
2 years agoBBB warns about travel scams
51 -
0:43
KMGH
2 years agoBBB warns about counterfeit items
52 -
0:53
KMGH
2 years agoBBB warns about weight loss supplements
15 -
1:14
Reuters
2 years agoWHO warns about Ukraine's 'humanitarian catastrophe'
158 -
0:41
KMGH
2 years agoBBB warns about crypto message on Instagram
31 -
1:58
WFTS
2 years agoFBI warns about popular Facebook scam
83 -
1:15:15
Havoc
7 hours agoTainted Careers & Tarnished Legacies | Stuck Off the Realness Ep. 14
52.8K9 -
1:05:33
Glenn Greenwald
1 day agoJournalist Chris Hedges on Media, Terror, Gaza, and More | SYSTEM UPDATE #338
75.4K108 -
1:14:10
Talk Nerdy 2 Us
17 hours agoHacks, Leaks & Big Tech Control: Is Your Data Under Siege by Shadow Powers?
23.4K3